Cargando…
Management of de novo metastatic hormone-sensitive prostate cancer: A comprehensive report of a single-center experience
BACKGROUND: Upfront docetaxel or novel hormonal agents (NHA) such as abiraterone and enzalutamide have become the standard of care for metastatic hormone sensitive prostate cancer (mHSPC). We evaluated real-world management of patients treated with these agents at a single center. PATIENTS AND METHO...
Autores principales: | Guin, Sunny, Liaw, Bobby K., Jun, Tomi, Ayers, Kristin, Patel, Bonny, O’Connell, Timmy, Deitz, Matthew, Klein, Michael, Mullaney, Tommy, Prentice, Tony, Newman, Scott, Fink, Marc, Zhou, Xiang, Schadt, Eric E., Chen, Rong, Oh, William K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390935/ https://www.ncbi.nlm.nih.gov/pubmed/35984843 http://dx.doi.org/10.1371/journal.pone.0264800 |
Ejemplares similares
-
Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma
por: Mack, Philip C, et al.
Publicado: (2022) -
Analysis of Real‐World Data to Investigate the Impact of Race and Ethnicity on Response to Programmed Cell Death‐1 and Programmed Cell Death‐Ligand 1 Inhibitors in Advanced Non‐Small Cell Lung Cancers
por: Ayers, Kristin L., et al.
Publicado: (2021) -
NxRepair: error correction in de novo sequence assembly using Nextera mate pairs
por: Murphy, Rebecca R., et al.
Publicado: (2015) -
Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer
por: Liaw, Bobby C, et al.
Publicado: (2022) -
De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995
por: Lord, SJ, et al.
Publicado: (2022)